Article
Deanticoagulated Heparins Mediate Goblet Cell Differentiation to Restore Mucosal Barrier for Ulcerative Colitis Therapy
2026-02-13
Abstract excerpt
Mucosal barrier dysfunction is a pathological hallmark of ulcerative colitis (UC), yet current clinical therapeutic strategies remain predominantly limited to anti-inflammatory therapies and/or surgical treatment, lack of reliable treatment for mucosal repairment 1,2 . Here, through a systematic screen of our established library for deanticoagulated heparins 3 , we found that the nonanticoagulant low-molecular-w...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 2ce9d29e-fcd8-5db9-8c30-9f7097edc51f
- DOI
- 10.64898/2026.02.12.705304
